Insider · CIK 0001292636

Tierney David S

Reports to the SEC for 5 companies · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001292636

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−383K sh	$31.50	−$12.1M	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−33.5K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−29.5K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,414 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,894 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,468 sh	—	—	0
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,334 sh	—	—	383,314
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,334 sh	—	—	178,163
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	381,980
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	179,497
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+947 sh	—	—	380,567
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−947 sh	—	—	180,910
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+18.1K sh	—	—	176,389
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,468 sh	—	—	181,857
2025-08-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$2.24	+$112K	405,620
2025-08-27	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−26K sh	$20.20	−$525K	379,620
2025-08-27	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	158,274
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	355,620
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	208,274
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	351,620
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	212,274
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	350,287
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	213,607
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+23.2K sh	—	—	212,179
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+2,841 sh	—	—	215,020
2024-08-22	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	—	—	188,931
2024-08-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$4.01	+$60.2K	363,874
2024-08-21	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−15K sh	$20.10	−$301K	348,874
2024-04-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$4.01	+$100K	373,874
2024-04-08	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−25K sh	$15.68	−$392K	348,874
2024-04-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	—	—	203,931
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	348,874
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	228,931
2024-01-02	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.13	+$11.3K	344,874
2024-01-02	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	232,931
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	334,874
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	242,931
2023-12-12	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$1.13	+$56.5K	383,541
2023-12-12	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−50K sh	$13.32	−$666K	333,541
2023-12-12	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	—	—	244,264
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+29.5K sh	—	—	290,024
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,240 sh	—	—	294,264
2023-05-11	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$0.79	+$15.8K	333,541
2023-05-11	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	260,500
2023-04-05	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$0.79	+$23.7K	343,541

Recent filings

Accepted (ET)
Jul 174
Tierney David S0001161697-26-000184
SEC(opens sec.gov)
Dec 304
Tierney David S0001161697-25-000496
SEC(opens sec.gov)
Dec 104
Tierney David S0001161697-25-000451
SEC(opens sec.gov)
Nov 244
Tierney David S0001161697-25-000424
SEC(opens sec.gov)
Aug 284
Tierney David S0001161697-25-000302
SEC(opens sec.gov)

Companies

Address

355 ALHAMBRA CIRCLE, SUITE 801

CORAL GABLES, FL, 33134